Related Experiment Video
Updated: Dec 17, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Safety of dietary supplements use among patients with cancer: A systematic review
Zhen Zeng1, Ahmed Ullah Mishuk2, Jingjing Qian2
1Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Abstract:
Dietary supplements (DS) are commonly taken by patients with cancer, but safety of DS use remains unclear. A systematic literature search was conducted using PubMed, ClinicalTrials.gov, International Pharmaceutical Abstracts and Alt HealthWatch databases from inception through October 12, 2018. Included studies were limited to clinical trials including patients with cancer, DS products as interventions, evaluation of safety endpoints of DS use, and published in English. Sixty-five studies were included to evaluate 20 different DS among patients with 12 types of cancer. Botanical DS (n = 13), vitamins (n = 8), and probiotics/synbiotics (n = 7) were the top 3 types of DS evaluated in these trials. Majority of studied DS appeared safe. Among 19 trials including patients with cancer undergoing chemotherapy, most (n = 18) of studied DS (e.g., vitamins, botanical, omega-3 fatty acid) were found to be safe. Evaluation of DS use and its safety should be regularly incorporated in clinical trials among patients with cancer.
Insights
Most dietary supplements (DS) appear safe for cancer patients, including those undergoing chemotherapy. Regular evaluation of DS safety in clinical trials is recommended for better patient care.
Area of Science:
- Oncology
- Pharmacology
- Nutritional Science
Background:
- Patients with cancer frequently use dietary supplements (DS).
- The safety of DS use in cancer patients is not well-established.
- Evidence-based guidelines for DS use in oncology are lacking.
Purpose of the Study:
- To systematically review the safety of dietary supplements used by cancer patients.
- To identify the types and safety profiles of DS evaluated in clinical trials.
- To inform clinical practice regarding DS use in cancer care.
Main Methods:
- Systematic literature search of PubMed, ClinicalTrials.gov, International Pharmaceutical Abstracts, and Alt HealthWatch databases.
- Inclusion criteria: clinical trials involving cancer patients, DS interventions, safety endpoints, and English language publication.
- Sixty-five studies evaluating 20 different DS across 12 cancer types were included.
Main Results:
- Botanical DS, vitamins, and probiotics/synbiotics were the most frequently studied DS types.
- The majority of evaluated DS demonstrated a good safety profile in cancer patients.
- In trials involving chemotherapy patients, most DS (e.g., vitamins, botanicals, omega-3 fatty acids) were found to be safe.
Conclusions:
- Most dietary supplements appear safe for patients with cancer.
- Regular incorporation of DS safety evaluations into clinical trials is crucial.
- Further research is needed to establish comprehensive safety guidelines for DS in oncology.
Related Concept Videos
Cancer Prevention
Some...
Cancer Survival Analysis
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bioavailability Study Design: Healthy Subjects Versus Patients
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
